Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tero-Pekka Alastalo

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|April 13, 2013
[Novel high-throughput sequencing strategies in genetic diagnostics]Samuel Myllykangas, Juha W Koskenvuo, Tero-Pekka Alastalo
Plos One|December 25, 2015
Prevalence of Titin Truncating Variants in General PopulationOyediran Akinrinade, Juha W Koskenvuo, Tero-Pekka Alastalo
American Journal of Medical Genetics. Part A|February 19, 2015
Expanding the phenotype of Timothy syndrome type 2: an adolescent with ventricular fibrillation but normal developmentAnita Hiippala, Jonna Tallila, Samuel Myllykangas, et al.
Purinergic Signalling|April 1, 2016
Extracellular ATP protects endothelial cells against DNA damageJoonas Aho, Mikko Helenius, Sanna Vattulainen-Collanus, et al.
Drug Discovery Today|June 24, 2014
Targeting the Wnt signaling pathways in pulmonary arterial hypertensionVinicio de Jesus Perez, Ke Yuan, Tero-Pekka Alastalo, et al.
Journal of Cell Science|July 17, 2003
Formation of nuclear stress granules involves HSF2 and coincides with the nucleolar localization of Hsp70Tero-Pekka Alastalo, Maria Hellesuo, Anton Sandqvist, et al.
Heart (British Cardiac Society)|April 8, 2016
Genetic testing and blood biomarkers in paediatric pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPKJoseph Pattathu, Matthias Gorenflo, Anne Hilgendorff, et al.
Annals of the New York Academy of Sciences|October 11, 2012
Therapeutic potential of thymosin β4 in myocardial infarct and heart failureChristoffer Stark, Pekka Taimen, Miikka Tarkia, et al.
American Journal of Medical Genetics. Part A|February 19, 2016
The rare Costello variant HRAS c.173C>T (p.T58I) with severe neonatal hypertrophic cardiomyopathyAnita Hiippala, Catalina Vasilescu, Jonna Tallila, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 28, 2012
Inhibiting NF-κB in the developing lung disrupts angiogenesis and alveolarizationCristiana Iosef, Tero-Pekka Alastalo, Yanli Hou, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Duodecim; Laaketieteellinen Aikakauskirja|April 13, 2013
[Novel high-throughput sequencing strategies in genetic diagnostics]Samuel Myllykangas, Juha W Koskenvuo, Tero-Pekka Alastalo
Plos One|December 25, 2015
Prevalence of Titin Truncating Variants in General PopulationOyediran Akinrinade, Juha W Koskenvuo, Tero-Pekka Alastalo
American Journal of Medical Genetics. Part A|February 19, 2015
Expanding the phenotype of Timothy syndrome type 2: an adolescent with ventricular fibrillation but normal developmentAnita Hiippala, Jonna Tallila, Samuel Myllykangas, et al.
Purinergic Signalling|April 1, 2016
Extracellular ATP protects endothelial cells against DNA damageJoonas Aho, Mikko Helenius, Sanna Vattulainen-Collanus, et al.
Drug Discovery Today|June 24, 2014
Targeting the Wnt signaling pathways in pulmonary arterial hypertensionVinicio de Jesus Perez, Ke Yuan, Tero-Pekka Alastalo, et al.
Journal of Cell Science|July 17, 2003
Formation of nuclear stress granules involves HSF2 and coincides with the nucleolar localization of Hsp70Tero-Pekka Alastalo, Maria Hellesuo, Anton Sandqvist, et al.
Heart (British Cardiac Society)|April 8, 2016
Genetic testing and blood biomarkers in paediatric pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPKJoseph Pattathu, Matthias Gorenflo, Anne Hilgendorff, et al.
Annals of the New York Academy of Sciences|October 11, 2012
Therapeutic potential of thymosin β4 in myocardial infarct and heart failureChristoffer Stark, Pekka Taimen, Miikka Tarkia, et al.
American Journal of Medical Genetics. Part A|February 19, 2016
The rare Costello variant HRAS c.173C>T (p.T58I) with severe neonatal hypertrophic cardiomyopathyAnita Hiippala, Catalina Vasilescu, Jonna Tallila, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 28, 2012
Inhibiting NF-κB in the developing lung disrupts angiogenesis and alveolarizationCristiana Iosef, Tero-Pekka Alastalo, Yanli Hou, et al.
Pageof 5